296 related articles for article (PubMed ID: 32276412)
21. Plasma chromogranin A in patients with sporadic gastro-entero-pancreatic neuroendocrine tumors or multiple endocrine neoplasia type 1.
Peracchi M; Conte D; Gebbia C; Penati C; Pizzinelli S; Arosio M; Corbetta S; Spada A
Eur J Endocrinol; 2003 Jan; 148(1):39-43. PubMed ID: 12534356
[TBL] [Abstract][Full Text] [Related]
22. Real-world treatment patterns, resource use and costs of treating uncontrolled carcinoid syndrome and carcinoid heart disease: a retrospective Swedish study.
Lesén E; Björstad Å; Björholt I; Marlow T; Bollano E; Feuilly M; Marteau F; Welin S; Elf AK; Johanson V
Scand J Gastroenterol; 2018 Dec; 53(12):1509-1518. PubMed ID: 30449217
[TBL] [Abstract][Full Text] [Related]
23. A Comprehensive Assessment of the Role of miRNAs as Biomarkers in Gastroenteropancreatic Neuroendocrine Tumors.
Malczewska A; Kidd M; Matar S; Kos-Kudla B; Modlin IM
Neuroendocrinology; 2018; 107(1):73-90. PubMed ID: 29566385
[TBL] [Abstract][Full Text] [Related]
24. Supportive therapy in gastroenteropancreatic neuroendocrine tumors: Often forgotten but important.
Jin XF; Spampatti MP; Spitzweg C; Auernhammer CJ
Rev Endocr Metab Disord; 2018 Jun; 19(2):145-158. PubMed ID: 29464446
[TBL] [Abstract][Full Text] [Related]
25. Bone health and vitamin D status in alcoholic liver disease.
Kizilgul M; Ozcelik O; Delibasi T
Indian J Gastroenterol; 2016 Jul; 35(4):253-9. PubMed ID: 27246833
[TBL] [Abstract][Full Text] [Related]
26. Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?
Barrea L; Muscogiuri G; Pugliese G; Modica R; Laudisio D; Aprano S; Faggiano A; Colao A; Savastano S
J Transl Med; 2021 Jul; 19(1):324. PubMed ID: 34330303
[TBL] [Abstract][Full Text] [Related]
27. Hypovitaminosis D and osteopenia/osteoporosis in a haemophilia population: a study in HCV/HIV or HCV infected patients.
Linari S; Montorzi G; Bartolozzi D; Borderi M; Melchiorre D; Benelli M; Morfini M
Haemophilia; 2013 Jan; 19(1):126-33. PubMed ID: 22776099
[TBL] [Abstract][Full Text] [Related]
28. Vitamin D Deficiency and Its Influence on Bone Metabolism and Density in a Brazilian Population of Healthy Men.
Moreira ML; Neto LV; Madeira M; Lopes RF; Farias MLF
J Clin Densitom; 2018; 21(1):91-97. PubMed ID: 28233710
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetics of gastroenteropancreatic neuroendocrine tumors.
Starker LF; Carling T
Curr Opin Oncol; 2009 Jan; 21(1):29-33. PubMed ID: 19125015
[TBL] [Abstract][Full Text] [Related]
30. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
31. Bone metabolism and vitamin D status in patients with multiple sclerosis.
Kępczyńska K; Zajda M; Lewandowski Z; Przedlacki J; Zakrzewska-Pniewska B
Neurol Neurochir Pol; 2016; 50(4):251-7. PubMed ID: 27375138
[TBL] [Abstract][Full Text] [Related]
32. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
[TBL] [Abstract][Full Text] [Related]
33. [Vitamin D deficiency and osteoporosis in a rural population of Cordoba province, Argentina].
Gobbi C; Salica D; Pepe G; Dotto G; Petenian E; Martínez F
Rev Fac Cien Med Univ Nac Cordoba; 2009; 66(3):103-12. PubMed ID: 21138667
[TBL] [Abstract][Full Text] [Related]
34. APOBEC3B High Expression in Gastroenteropancreatic Neuroendocrine Neoplasms and Association With Lymph Metastasis.
Feng C; Zheng Q; Yang Y; Xu M; Lian Y; Huang J; Jiang Y
Appl Immunohistochem Mol Morphol; 2019 Sep; 27(8):599-605. PubMed ID: 30095460
[TBL] [Abstract][Full Text] [Related]
35. Predictors of long-term outcome in patients with well-differentiated gastroenteropancreatic neuroendocrine tumors after peptide receptor radionuclide therapy with 177Lu-octreotate.
Ezziddin S; Attassi M; Yong-Hing CJ; Ahmadzadehfar H; Willinek W; Grünwald F; Guhlke S; Biersack HJ; Sabet A
J Nucl Med; 2014 Feb; 55(2):183-90. PubMed ID: 24434296
[TBL] [Abstract][Full Text] [Related]
36. Relationship between vitamin D status, parathyroid hormone levels and bone mineral density in patients with chronic kidney disease stages 3 and 4.
Stavroulopoulos A; Porter CJ; Roe SD; Hosking DJ; Cassidy MJ
Nephrology (Carlton); 2008 Feb; 13(1):63-7. PubMed ID: 18199106
[TBL] [Abstract][Full Text] [Related]
37. Epidemiological features of gastroenteropancreatic neuroendocrine tumors in Chengdu city with a population of 14 million based on data from a single institution.
Guo LJ; Wang CH; Tang CW
Asia Pac J Clin Oncol; 2016 Sep; 12(3):284-8. PubMed ID: 27170574
[TBL] [Abstract][Full Text] [Related]
38. Nutritional and vitamin status in patients with neuroendocrine neoplasms.
Clement DS; Tesselaar ME; van Leerdam ME; Srirajaskanthan R; Ramage JK
World J Gastroenterol; 2019 Mar; 25(10):1171-1184. PubMed ID: 30886501
[TBL] [Abstract][Full Text] [Related]
39. Clinical and functional implication of the components of somatostatin system in gastroenteropancreatic neuroendocrine tumors.
Herrera-Martínez AD; Gahete MD; Pedraza-Arevalo S; Sánchez-Sánchez R; Ortega-Salas R; Serrano-Blanch R; Luque RM; Gálvez-Moreno MA; Castaño JP
Endocrine; 2018 Feb; 59(2):426-437. PubMed ID: 29196939
[TBL] [Abstract][Full Text] [Related]
40. Systemic inflammatory mediators and bone homeostasis in intestinal failure.
Compher C; Pazianas M; Benedict S; Brown JC; Kinosian BP; Hise M
JPEN J Parenter Enteral Nutr; 2007; 31(2):142-7. PubMed ID: 17308255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
